<DOC>
	<DOCNO>NCT01116024</DOCNO>
	<brief_summary>This prospective , non-randomized , multi-center study design evaluate safety effectiveness ATS 3f Enable Aortic Bioprosthesis patient population undergo isolated aortic valve replacement without concomitant procedure . The Enable Aortic Valve equine pericardial stented bioprosthesis .</brief_summary>
	<brief_title>ATS 3f Enable ( tm ) Aortic Bioprosthesis , Model 6000</brief_title>
	<detailed_description>The ATS 3f Enable Aortic Bioprosthesis intend patient whose prognosis without surgical replacement diseased natural valve unacceptably poor term survival and/or quality life opinion attend physician . For patient , number widely accept prosthetic heart valve use .</detailed_description>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>The patient require isolated aortic valve replacement without concomitant procedure coronary artery bypass another valve repair . ( The three remain valve must native tissue ) . The patient geographically stable willing return implant site followup visit . The patient adequately informed risk requirement consent his/her participation clinical study . If patient female childbearing potential , patient negative pregnancy test within seven ( 7 ) day prior study procedure . The patient require replacement two valve . The patient &lt; 20 year age . The patient noncardiac major progressive disease , Investigator 's experience produce unacceptable increase risk patient , result life expectancy le 24 month . The patient intravenous drug and/or alcohol abuser . The patient present active endocarditis systemic infection . The patient previous valve replacement surgery , include previous implant explant ATS 3f Enable Aortic Bioprosthesis ( Model 6000 ) placement rigid annuloplasty ring mitral position . The patient participate concomitant research study investigational product . The patient present dilatation ascend aorta , Marfan Syndrome , EhlersDanlos syndrome , cystic medial degeneration , condition cause ascend aorta irregular geometry physiology see via preoperative imaging . The patient chronic renal failure .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Diseased Heart Valve , Replacement , Aortic</keyword>
</DOC>